|
J Biol Chem, Vol. 274, Issue 30, 20839-20846, July 23, 1999
Different Membrane Anchoring Positions of Tryptophan and
Lysine in Synthetic Transmembrane -Helical Peptides*
Maurits R. R.
de Planque §,
John A. W.
Kruijtzer¶,
Rob M. J.
Liskamp¶,
Derek
Marsh ,
Denise V.
Greathouse**,
Roger E.
Koeppe II**,
Ben
de
Kruijff , and
J. Antoinette
Killian
From the Department Biochemistry of Membranes, Center
for Biomembranes and Lipid Enzymology, Institute of Biomembranes,
Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands, the
¶ Department of Medicinal Chemistry, Utrecht University,
Sorbonnelaan 16, 3584 CA Utrecht, The Netherlands, Abteilung
Spektroskopie, Max-Planck-Institut für biophysikalische
Chemie, D-37077 Göttingen, Germany, and the ** Department of
Chemistry and Biochemistry, University of Arkansas,
Fayetteville, Arkansas 72701
 |
ABSTRACT |
Specific interactions of membrane proteins with
the membrane interfacial region potentially define protein position
with respect to the lipid environment. We investigated the proposed
roles of tryptophan and lysine side chains as "anchoring" residues
of transmembrane proteins. Model systems were employed, consisting of
phosphatidylcholine lipids and hydrophobic -helical peptides,
flanked either by tryptophans or lysines. Peptides were incorporated in
bilayers of different thickness, and effects on lipid structure were
analyzed. Induction of nonbilayer phases and also increases in bilayer
thickness were observed that could be explained by a tendency of Trp as
well as Lys residues to maintain interactions with the interfacial region. However, effects of the two peptides were remarkably different, indicating affinities of Trp and Lys for different sites at the interface. Our data support a model in which the Trp side chain has a
specific affinity for a well defined site near the lipid carbonyl
region, while the lysine side chain prefers to be located closer to the
aqueous phase, near the lipid phosphate group. The information obtained
in this study may further our understanding of the architecture of
transmembrane proteins and may prove useful for refining prediction
methods for transmembrane segments.
 |
INTRODUCTION |
In biological membranes, a variety of interactions can occur
between lipids and proteins that affect protein as well as lipid properties and in which both the hydrophobic membrane core and the more
polar membrane interfaces can be involved (1-3). Membrane proteins are
able to span the lipid bilayer through interactions of their exposed
hydrophobic segments with the lipid hydrocarbon acyl chains. In
general, the length of these hydrophobic segments will approximately
match the membrane hydrophobic thickness. However, also a
mismatch between protein hydrophobic length and
membrane hydrophobic thickness may occur. Such a mismatch can have
considerable influence on membrane structure and function (reviewed in
Ref. 4) and may, for example, be involved in protein sorting,
microdomain formation, changes in protein activity, or changes in lipid
structure and organization.
In contrast to the hydrophobic core of a membrane, the membrane
interface presents a complex and heterogeneous chemical environment, which accounts for a relatively large proportion of the total bilayer
thickness (3). Specific interactions of membrane proteins with the
interfacial region of the lipids may influence many functional processes, such as for instance membrane protein assembly, topology of
membrane proteins, the mode of protein insertion into the membrane, and
protein anchoring to the membrane. In addition, such interactions may
play a determining role in hydrophobic mismatch (4).
Analyses of the structure of transmembrane proteins suggest that two
types of amino acids may be of special importance for interactions of
membrane proteins with the interfacial region: aromatic amino acids, in
particular tryptophans, which are enriched at both ends of
transmembrane fragments (5-9) and appear to have a preferred
interaction with the interface (10), and charged residues, which also
are preferentially located near the membrane interfaces (11).
Positively charged residues interact with negatively charged
phospholipids and are predominantly positioned at the cytoplasmic side,
according to the positive inside rule (11).
In this study, we aim to investigate the role of interfacially
localized aromatic tryptophans and positively charged lysines in
protein-membrane interfacial interactions by using a strategy that is
based on hydrophobic mismatch effects. We shall employ artificial
peptides of variable hydrophobic length, flanked by either tryptophan
or lysine residues. These peptides will be incorporated in lipid
bilayers of varying thickness, allowing a wide range of mismatch
situations. Upon creating such a hydrophobic mismatch, it can be
expected that the lipid structure will readjust if the residues
flanking the hydrophobic segment of the peptide prefer to maintain
interactions with the lipid head group region. Analysis of the effects
on lipid organization will thus provide information on the interaction
of these flanking residues with the interfacial region.
Indeed, we have shown earlier, using simple model systems, that
hydrophobic mismatch can result in complementary lipid conformational changes (10, 12). It was concluded that the affinity of flanking tryptophan residues for the interface might be important in determining both the nature and extent of changes in lipid organization. In the
present study, we compared the effect of tryptophan and lysine as
flanking residues on lipid structure. Striking differences were
observed between the membrane-associating and lipid-modulating properties of Lys- and Trp-flanked model peptides. The results suggest
that tryptophan residues prefer to be located in a well defined region
at the polar/apolar interface in phosphatidylcholine bilayers near the
lipid carbonyls, while lysine residues prefer to be localized near the
more polar region around the lipid phosphate group or more outward
toward the aqueous phase.
 |
EXPERIMENTAL PROCEDURES |
Materials
WALP1 peptides (see
Table I) were synthesized by previous methods (10, 13), except that
acetyl-Gly was used in place of formyl-Ala as the N-terminal residue,
and the resin cleavage step was performed using ethanolamine at room
temperature (14). When necessary (<90% purity), peptides were
purified by HPLC. The identity of the peptides was confirmed by fast
atom bombardment mass spectrometry or electrospray mass spectrometry.
The KALP peptides (Table I) were
synthesized on an automatic ABI 433A peptide synthesizer using the ABI
FastMoc 0.25 mmol protocols (49, 50), except that the coupling time was
45 min instead of 20 min. Fmoc
(N-(9-fluorenyl)methoxycarbonyl) amino acid derivatives,
activated in situ using
2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate/1-hydroxybenzotriazole and
N,N'-diisopropylethylamine in
N-methylpyrrolidinone, were used in the coupling steps. The peptide was deprotected and cleaved from the resin by treatment with 10 ml of trifluoroacetic acid, 0.25 ml of H2O, and 0.25 ml of
triisopropylsilane for 2 h at room temperature. Finally, the peptide was precipitated in a methyl tert-butyl
ether/n-hexane (1:1, v/v) solution. After this, the pellet
was dissolved in tert-butanol/water (1:1, v/v) (~60 ml)
and lyophilized to obtain the crude peptide as a white fluffy solid,
which was 90% pure according to analytical HPLC. The identity of the
peptides was confirmed by fast atom bombardment mass spectrometry or
electrospray mass spectrometry.
All of the phospholipids were purchased from Avanti Polar Lipids Inc.
(Birmingham, AL). Deuterium-depleted water was from Isotec Inc.
(Miamisburg, OH).
n-(N-Oxy-4,4-dimethyloxazolidin-2-yl) stearic
acid (n-SASL) isomers were synthesized according to Hubbell and McConnell (15).
Methods
Sample Preparation--
The procedure followed for WALP analogs
is identical to methods used in earlier work (10, 12). WALP analogs,
quantified by the absorbance of tryptophan at 280 nm, were predissolved
in 10 µl of trifluoroacetic acid/mg of peptide and were two times dissolved in 1 ml of trifluoroethanol, followed by drying in a rotary
evaporator. Unless stated otherwise, the peptides were dissolved in 0.5 ml of trifluoroethanol and added, at temperatures above the gel to
liquid crystalline phase transition, to 0.5 ml of a lipid suspension in
distilled water, followed by the addition of 10 ml of water and
immediate lyophilization. For some experiments, a mixed film method was
used, in which the similarly treated peptide was added to 0.5 ml of a
lipid suspension in methanol, followed by drying in a rotary evaporator
and overnight incubation under high vacuum. Control experiments showed
that both methods yielded identical results (data not shown). KALP
peptides were quantified by their dry weight, and samples were prepared
with the mixed film method. Further sample preparation depended on
the kind of measurement (see below).
31P NMR Measurements--
Lipid/peptide mixtures
with a 1:10 peptide/lipid molar ratio (containing 20 µmol of lipid)
were hydrated in 1.5 ml of buffer (100 mM NaCl, 25 mM Tris, pH 7.4). Samples were spun down at 30,000 × g for 15 min at 4 °C, and the supernatant was removed.
The pellet was washed with buffer if the pH of the supernatant was
below pH 6. 31P NMR spectra of the pellets were recorded on
a Bruker MSL 300 spectrometer. The sample temperature was regulated
using a Bruker B-VT1000 temperature controller. Proton-decoupled
experiments were carried out at 121.5 MHz, with a 17-µs 90° pulse,
a 1.3-s interpulse time, and gated proton-noise decoupling. A sweep
width of 25 kHz, 1024 data points, and a 100-Hz line broadening were used, and approximately 15,000 scans were acquired.
Circular Dichroism--
CD samples of pure peptide were prepared
by adding 1 ml of buffer (100 mM NaCl, 25 mM
Tris, pH 7.4) to 1 µmol of peptide powder and subsequent vortexing.
CD spectra were recorded without any further sample processing. Samples
containing lipids were prepared as described above and were hydrated in
1 ml of buffer that was diluted with distilled water (1:1, v/v), unless
otherwise stated, to obtain a better signal-to-noise ratio. These
samples were then sonicated for 5 min with a 50% duty cycle and with
an input power of 40 watts, using a Branson 250 tip sonicator. To
pellet down titanium particles and any residual multilamellar lipid
structures, the sonicated samples were next centrifuged at 30,000 × g for 15 min at 4 °C. Spectra of oriented
peptide/lipid systems, hydrated with distilled water instead of buffer,
were measured after spreading 40 µl of a sonicated sample on a quartz
plate, followed by air drying. For all samples, CD measurements were
carried out on a Jasco J-600 spectropolarimeter, using a 0.2-mm path
length cell, 1-nm bandwith, 0.2-nm resolution, 1-s response time, and a
scan speed of 20 nm/min. Unless otherwise noted, spectra were recorded at room temperature.
2H NMR Measurements--
Samples containing peptide
and 10 µmol of sn-2 perdeuterated 14:0-PC at a 1:30 molar
ratio were hydrated in 1 ml of deuterium-depleted water. The samples
were spun down at 30,000 × g for 15 min at 4 °C,
and the supernatant was removed. The pellet was washed with deuterium-depleted water if the pH of the supernatant was below pH 6. 2H NMR spectra of the pellets were recorded on a Bruker MSL
300 spectrometer, using a high power probe with a 7.5-mm solenoidal sample coil. 2H NMR measurements were performed at 46.1 MHz, using a quadrupolar echo sequence (16) with a 2.6-µs 90°
pulse, a 50-µs pulse separation, a repetition rate of two
acquisitions per second, and a spectral width of 417 kHz, with 2048 data points in the time domain. Approximately 80,000 scans were
accumulated. The free induction decays were left-shifted to begin at
the top of the echo, zero-filled to 8192 points, and multiplied with an
exponential window function equivalent to a line broadening of 50 Hz.
Spectra were recorded at 34 °C.
Analysis of the 2H NMR Spectra--
2H
NMR powder spectra were dePaked as described earlier (12). This
dePakeing procedure results in spectra that would be obtained for an
aligned membrane with its bilayer normal parallel to the magnetic
field. It enhances the resolution and results in doublets with
splittings  Q that relate to the segmental order
parameter S(i). Order parameter profiles were
obtained by assuming that the segmental order varies monotonically
along the acyl chain. From these profiles, the effective length of the
acyl chains was estimated as described (12).
ESR Measurements--
Both KALP and WALP-containing samples were
prepared by a mixed film method, as described earlier (12). Dried
peptide/14:0-PC films (containing 1.5 µmol of lipid) with a 1:30 or
1:10 molar ratio, doped with 1 mol % of n-SASL, were
hydrated in 40 µl of distilled water. Samples were spun down at
5000 × g for 15 min at room temperature in 1-mm inner
diameter capillaries, which were flame-sealed after removal of the
supernatant. ESR spectra were recorded on a Varian Century Line Series
9-GHz spectrometer equipped with a nitrogen gas flow temperature
regulation system. Sample-containing capillaries were accommodated
within standard 4-mm quartz ESR tubes containing light silicone oil for
thermal stability. Temperature was measured by a fine wire thermocouple located at the top of the microwave cavity within the silicone oil.
Conventional, in-phase ESR spectra were recorded at 34 °C, at a
modulation amplitude of 1.6 G peak-to-peak and a modulation frequency
of 100 kHz with a sweep width of the static field of 100 G.
 |
RESULTS |
Effects of Short KALP and WALP Analogs on Lipid Phase
Behavior--
In a previous study, we showed that short
tryptophan-flanked peptides have a pronounced effect on lipid
conformation, inducing inverted hexagonal (HII) phases at
high concentration in bilayer-preferring phosphatidylcholine lipids. To
discover whether this behavior is a unique property of Trp-flanked
peptides, we first compared the effect of the lysine-containing peptide
KALP16 on the phase behavior of 18:1c-PC lipids with that
of the tryptophan-containing peptide WALP16. 31P NMR
spectra of these systems at a 1:10 peptide/lipid molar ratio are shown
in Fig. 1. Pure 18:1c-PC
gives a spectrum with a low field shoulder and a high field peak,
typical for the preferred planar bilayer organization of this lipid in
the liquid crystalline (L ) phase (17, 18). WALP16
associates completely with the lipids and partially induces an
HII phase, as characterized by the spectral component with
inverted asymmetry and a 2-fold reduced residual chemical shift
anisotropy compared with the L spectrum (17, 18).
Although KALP16 has the same backbone length as WALP16, it does not
change the lamellar phase preference of this lipid. This strikingly
different behavior suggests that the Lys-flanked peptides either are
unable to induce nonbilayer phases in PC or do not incorporate in the
membrane.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 1.
31P NMR spectra of dispersions of
18:1c-PC in the absence and presence of KALP16 or WALP16,
as indicated in the figure, at a molar peptide/lipid
ratio of 1:10 at 30 °C.
|
|
Solubility Properties and Conformational Behavior of KALP and WALP
Analogs--
It is possible that KALP16, which is less hydrophobic
than WALP16, does not incorporate into the membrane because it is
soluble in buffer. To investigate the behavior of KALP and WALP analogs in buffer solution, circular dichroism measurements were performed. CD
spectra of dried peptide films, hydrated with buffer, are shown in Fig.
2. A clear solution of WALP16 in buffer
could not be achieved, and the CD signals obtained were equivalent to
the background signal, indicating that all of the WALP had aggregated.
A similar behavior was observed for WALP23 (data not shown). In
contrast, both KALP16 and KALP19 formed clear solutions in buffer and
gave well defined CD spectra corresponding to 15 and 40% -helix,
respectively, indicating that the longer peptide forms a more stable
helix, as is commonly observed (e.g. Ref. 19). KALP23 again
did not give a clear solution, and only a very weak signal was
observed, suggesting that this longer peptide is too hydrophobic to
solubilize in the buffer solution. These results suggest that short
KALP peptides prefer not to associate with the membrane because they are soluble in buffer solution. Indeed, spinning down the
KALP16/18:1c-PC NMR sample yielded a supernatant with a CD
spectrum (not shown) that was very similar to that of pure KALP16 in
Fig. 2. Thus, longer KALP peptides are required to establish whether
Lys-flanked peptides are capable of inducing nonbilayer phases and/or
changes in lipid chain configuration in phosphatidylcholine
membranes.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 2.
Circular dichroism spectra of KALP16
(a), KALP19 (b), KALP23
(c), and WALP16 (d) in buffer at a
concentration of 1 mM at room temperature.
|
|
Effects of Longer KALP and WALP Analogs on Lipid Phase
Behavior--
The KALP23 analog has little structure in buffer
solution but adopts an -helical conformation in a lipid environment
(see below), also in the presence of the longest lipids used in this study (data not shown). This indicates solubilization of (at least a
large fraction of) KALP23 in a membrane environment under mismatch conditions (see also Refs. 20 and 21). To investigate the consequences
of mismatch on lipid phase behavior, 20:1c-,
22:1c-, and 24:1c-PC were selected, which have
a large bilayer thickness compared with the length of KALP23 and
corresponding WALP analogs. The 31P NMR spectra of KALP23
and of WALP23, WALP21, and WALP19 at a 1:10 molar ratio of peptide to
lipid are shown in Fig. 3. Spectra were
recorded at both 30 and 60 °C to investigate the temperature dependence of the lipid phase modulation. In the absence of peptide, all lipids depicted are in the L phase. The spectrum of
KALP23 in 24:1c-PC at 30 °C has components in the line
shape that deviate from that of a bilayer phase but cannot be
interpreted unambiguously in terms of nonbilayer phases. It does
confirm, however, that the peptide is associated with the membrane.
Raising the temperature to 60 °C results in a line shape that
contains a component clearly representative of a HII phase.
This has not previously been reported for Lys-based transmembrane
peptides and indicates the ability of these peptides to induce
HII phase formation in PC in response to mismatch.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 3.
31P NMR spectra of dispersions of
20:1c, 22:1c, and 24:1c-PC, in the
absence and presence of KALP23, WALP23, WALP21, or WALP19 at 30 °C
(A) and 60 °C (B), as indicated in
the figure, with a molar ratio of peptide to lipid of
1:10.
|
|
Also for KALP23 in the 20:1c and 22:1c-PC
systems, a higher temperature is necessary to obtain resolution of the
two spectral components, but in these systems an isotropic signal, most
probably a cubic-like lipid phase (10), is obtained, together with an L component. With even shorter lipids, spectra at both
temperatures are representative of pure L phases (data
not shown). This behavior is similar to that previously observed for
short WALP peptides, which upon increasing the lipid length first
induced an L I transition and then, at larger
mismatch, an I HII transition. Both transitions are
very sensitive to the exact length difference of the particular WALP/PC
combination (10). Therefore, the effects on phase behavior can be used
as a tool to compare the effective hydrophobic length of KALP23 with
that of corresponding WALP analogs.
As shown in Fig. 3, the tryptophan peptide WALP23 behaves very
differently from its corresponding Lys analog KALP23. WALP23 does not
induce an HII phase and is much more efficient in inducing nonbilayer phases at lower temperature than is KALP23. Nearly or
totally pure isotropic phases are formed already at room temperature in
the three PC systems studied, and increasing the temperature has only a
minor effect, in agreement with previous observations with shorter WALP
analogs (22). The fact that an almost pure isotropic phase is induced
in 24:1c-PC suggests a smaller mismatch with this membrane
than in the case of KALP23 (see "Discussion"). To obtain more
information about this mismatch difference, WALP peptides with a
shorter hydrophobic length were also employed. With WALP21 and WALP19
(Fig. 3) the I HII transition occurs between
22:1c and 24:1c-PC and between
20:1c and 22:1c-PC, respectively. From these
data, it can be concluded that KALP23 has the same effect on the I HII transition as a shorter WALP peptide, approximately equal to WALP21 and certainly longer than WALP19. Thus, KALP23 behaves
as if it has the same hydrophobic length as a shorter WALP peptide,
indicating that the effective hydrophobic length of the peptides is
related to the nature of the flanking residues.
Effects of Longer KALP and WALP Analogs on Bilayer Thickness and
Lipid Dynamics--
For studying mismatch-induced lipid deformation in
situations where the peptide is relatively long with respect
to the hydrophobic bilayer thickness, we investigated the ability of
peptides to influence the molecular order of the lipid acyl chains,
while the overall organization remains an L lipid phase.
To this end, KALP23 and WALP23 were incorporated at a 1:30
peptide/lipid molar ratio into bilayers of 14:0-PC with perdeuterated
sn-2 chains. 31P NMR measurements confirmed that
the lipids in these systems are in a bilayer organization, and the
effects of the peptides on acyl chain order were characterized by
2H NMR.
Fig. 4 presents the 2H NMR
spectra of 14:0-PC bilayer dispersions, with and without KALP23 or
WALP23. Visual inspection of the spectrum representing the
KALP23/14:0-PC system reveals a very small increase in quadrupolar
splittings for the central methyl and the outer methylene peaks,
relative to the pure 14:0-PC. These splittings are significantly larger
for the WALP23 peptide, suggesting that the tryptophan-based peptides
thicken the 14:0-PC membrane more than do their lysine-based
counterparts. Segmental order parameters S(i)
were derived, and from these the mean hydrophobic thicknesses of the
different lipid/peptide systems were quantified, as described under
"Methods." The resulting values are presented in Table
II, together with the data obtained
previously for WALP16 and WALP19. For the pure 14:0-PC system, a value
of 22.5 Å was obtained, which is in fairly good agreement (within 1 Å) with values based on x-ray measurements (23). Previously, we have shown for shorter WALP peptides that the 14:0-PC bilayer thickness increases with increasing peptide length, giving small but very systematic effects (12). The longer WALP23 analog continues this trend,
but the effect of the lysine-based KALP23 peptide is even smaller than
that of the shortest WALP analog. Thus WALP peptides are more effective
modulators of 14:0-PC bilayer thickness than are KALP analogs. However,
direct comparison of the effects of WALP23 and KALP23 is only possible
when these peptides incorporate in 14:0-PC membranes with the same
efficiency, have similar orientations with respect to the bilayer
normal, and are in a similar aggregation state. We therefore analyzed
these systems by CD and by ESR. The latter technique additionally
yields information about the influence of the peptides on lipid
dynamics.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 4.
2H NMR spectra for
peptide/14:0-PC-d27 dispersions at a 1:30
molar ratio and at 34 °C. Spectra are shown without peptide
(14:0-PC) and for samples containing the peptides indicated.
|
|
View this table:
[in this window]
[in a new window]
|
Table II
Changes in mean hydrophobic thickness ( d) relative to the pure sn-2
chain perdeuterated 14:0-PC, for systems at a 1:30 molar ratio of
peptide to lipid and in anisotropy of the hyperfine splittings,
(Amax Amin), of the 14-SASL spin label relative
to 14:0-PC systems at a 1:10 peptide/lipid molar ratio.
Measurements were performed at 34 °C, 10 °C above the main phase
transition temperature of the pure 14:0-PC. The estimated experimental
precision in hydrophobic thickness is ±0.1 Å, and the precision in
(Amax Amin) is ±0.2 G.
|
|
CD spectra of both peptides at a 1:30 peptide/14:0-PC molar ratio at
34 °C are shown in Fig. 5. Both KALP23
and WALP23 are in an -helical conformation (curves
a), as deduced from the minima near 222 and 208 nm, the
crossover at 202 nm, and the maximum near 192 nm (24). From the
spectral intensities, it can be concluded that equivalent amounts of
KALP23 and WALP23 are associated with the membrane. The oriented
spectrum (curve b) of KALP23 is characteristic of
a helix with its long axis parallel to the incoming light (25). This
implies a transmembrane orientation, perhaps with a minor tilt angle
(<10 degrees) with respect to the bilayer normal, as judged from
reference spectra that were calculated with the method described by De
Jongh et al. (25). The oriented spectrum of WALP23 has an
identical crossover point but a shifted minimum with respect to the
spectrum corresponding to KALP23. The different line shape in the
220-235-nm region may be related to the tryptophan side chain
chromophores in WALP23, which contribute to the CD signal in this
spectral region (26). Thus, it can be concluded that both WALP23 and
KALP23 are incorporated to equivalent extents as transmembrane
-helical peptides in 14:0-PC without a significant tilt angle with
respect to the bilayer normal.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 5.
Circular dichroism spectra of WALP23
(A) and KALP23 (B) in 14:0-PC at a
1:30 molar ratio of peptide to lipid at 34 °C in sonicated vesicles
in excess water (a) and oriented bilayers
(b). The ellipticity of the oriented spectra
(b) is not absolute and is scaled to that of the nonoriented
spectra (a).
|
|
ESR spectra of systems doped with spin-labeled lipid probes
(n-SASL) were recorded to investigate the restriction of
chain dynamics by KALP23 and WALP23 in 14:0-PC. Peptide assemblies that specifically restrict the rotational motion of the lipid acyl chains,
induce a "restricted" ESR spectral component, which has been
related to the peptide aggregational state (27, 28). Samples were first
prepared with a 1:30 molar ratio of peptide to lipid. The resultant
spectra were rather similar to those of the pure lipid (data not
shown), and apparently overall lipid dynamics were not severely
affected at this ratio, as deduced from the spectral line widths in the
absence of peptide. The peptide concentration was therefore increased
to 10 mol %, yielding the spectra depicted in Fig.
6. Pure 14:0-PC with 14-SASL in the
L phase is characterized by a spectrum with three sharp,
symmetrical, quasi-isotropic peaks. Substantial changes in both line
shape and anisotropy of the hyperfine splitting were observed upon
incorporation of WALP23 and to a lesser extent on incorporation of
KALP23; i.e. WALP23 influences the lipid order and dynamics
to a considerably higher degree than does KALP23 (note the higher
degree of asymmetry in the high field peak). The ESR results on
peptide-induced changes in lipid chain motion parallel the trends
observed in the 2H NMR experiments. The increase in
spectral anisotropy, (Amax Amin) of 14-SASL, in the presence of the various
peptides, is compared with the 2H NMR results in Table II.
A similar ordering in the values of (Amax Amin) is also found for the 5-SASL spin label,
in which the ESR reporter group is positioned closer to the polar end
of the chain (data not shown, but see Ref. 12). However, even at the
relatively high peptide/lipid molar ratio used, there is no evidence
for a second, more motionally restricted spin-labeled lipid
component,2 such as is
generally observed for spin labels at the 14-C atom position with large
integral proteins or oligomeric transmembrane peptides (2, 29). Only
when the peptide/lipid molar ratio in 14:0-PC was increased to 1:6, for
which peptide aggregation might be expected, was there an indication of
a motionally restricted population of 14-SASL at 30 °C. The
inference that can be drawn from these results is that, at the molar
ratio used in the 2H NMR studies, both KALP23 and WALP23
are probably present as monomeric transmembrane helices and not as
extensive oligomers.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 6.
ESR spectra of the 14-SASL stearic acid spin
label in 14:0-PC, in the absence and in the presence of the peptides
indicated, at a peptide/lipid molar ratio of 1:10 and 34 °C (total
scan width = 100 G).
|
|
 |
DISCUSSION |
In this study, we investigated the roles of tryptophan and lysine
side chains as interfacial "anchoring" residues in transmembrane protein segments. Systems were created with a hydrophobic mismatch between peptides and lipids, and effects on lipids were studied. Striking differences in response were observed for both families of
peptides. Here we will discuss these results and their implications.
Effects on Lipid Structure of Relatively Short Peptides--
The
situation of having progressively shorter WALP or KALP peptides
incorporated into PC model membranes is equivalent to the situation in
which either Trp or Lys is gradually moved toward the hydrophobic
membrane region. The observed formation of nonbilayer phases as a
response to such a hydrophobic mismatch can be understood on the basis
that such nonbilayer structures contain areas of reduced hydrophobic
"membrane" thickness, that better match the hydrophobic length of
relatively short peptides (10).
It was found that both KALP23 and WALP23 are capable of inducing
nonbilayer phases, demonstrating that this lipid-modulating effect is
not specific for Trp-flanked peptides. Furthermore, KALP23 induces
essentially the same nonbilayer phases as the shorter WALP21. This
shows that the effective hydrophobic length of the peptides is
dependent on the nature of the flanking residues. This is supported
also by studies on a WALP analog with the same total length but with
its tryptophan residues shifted one position inward.3 These studies
indicated that the effects on PC organization depend on the distance
between the Trp residues and not on the total peptide length,
suggesting that indeed the flanking Trp residues delimit the peptide
hydrophobic stretch.
The results obtained in the present study allow us to interpret the
lipid-modulating properties of relatively short KALP and WALP peptides
in terms of Lys and Trp location in the membrane. Such an
interpretation requires consideration of the orientations of these side
chains in a lipid environment. Space-filling models of WALP23 and
KALP23 were built. The Trp torsion angles were based on the structure
of membrane-embedded gramicidin (30, 31), in which the imino moiety of
the rigid Trp indole side chain is pointing outward to the aqueous
phase, an orientation that is also proposed for membrane-associating
indole analogs (32). The flanking Lys side chains in KALP23 are modeled
with the charged terminus pointing toward the aqueous phase. This Lys
"snorkling" has been proposed for relatively short peptides, to
avoid the burying of charges in the hydrophobic membrane core (33, 34). Resulting peptide dimensions are given in Table
III.
View this table:
[in this window]
[in a new window]
|
Table III
Distance from the bilayer center of characteristic groups of
24:1c-PC and 14:0-PC in the liquid crystalline state and of the
position of characteristic side chain groups of KALP23, WALP23, and
WALP21 analogs
Average lipid phosphate positions were obtained by x-ray diffraction
(23) and were extrapolated to C=O positions based on combined x-ray and
neutron diffraction data of 18:1c-PC (35, 36). Amino acid side
chain positions were taken from peptide models built using InsightII
(version 98.0, Molecular Simulations Inc., San Diego, CA), based on an
ideal -helical conformation. The resulting WALP23 model was
energy-minimized using Discover (Molecular Simulations). The average
position of the two terminally located Trp or Lys residues (see
"Discussion") is given.
|
|
When comparing the two peptides, the Lys
-NH3+ group extends about 1.9 Å farther from the membrane center than does the Trp indole NH. KALP23
induces nonbilayer phases similar to those of WALP21. This
implies an additional difference of one residue at each end of the
peptide, corresponding to a side chain extension of 1.5 Å (in an
-helical conformation). Thus, adding the two factors, we conclude
that the localization that is still favorable for a Lys
-NH3+ in a lipid bilayer is
approximately 3.4 Å closer to the aqueous phase than that of a Trp NH.
In a fluid phase PC bilayer, this distance corresponds approximately to
the spacing between the lipid carbonyl and phosphate groups (Table
III).
In 24:1c-PC, WALP21 and KALP23 induce an HII
phase, indicating a large extent of hydrophobic mismatch. The expected
positions of the Trp and Lys side chains for these peptides are well
below the carbonyl and phosphate region in the 24:1c-PC
bilayer, respectively (Table III). We propose that the Trp indole group
disfavors a position with the imino moiety below the lipid carbonyl
region and that the Lys -NH3+ groups
disfavor a position below the lipid phosphate region. Therefore, the
positions of these side chains with respect to the membrane lipids
would determine the extent of hydrophobic mismatch.
Effects on Lipid Structure of Relatively Long Peptides--
With
peptide/lipid combinations that are equivalent to moving the Lys and
Trp residues outward in the direction of the aqueous phase, a different
response of the membrane system is expected. WALP23 increases the
bilayer thickness in this situation. As seen from the dimensions given
in Table III, the tryptophans in this peptide would be located close to
the polar lipid phosphate region in an unperturbed 14:0-PC bilayer.
Because the lipid system responds to WALP23 incorporation with a
stretch of its acyl chains, it is concluded that such a position of the
Trp side chain is unfavorable and that Trp prefers a more hydrophobic
interfacial environment. This is in accordance with water/membrane
partitioning studies with small unstructured peptides (37).
KALP23 has only a small effect on acyl chain order and dynamics, in
agreement with work on a comparable Lys-flanked polyleucine peptide (38, 39). Nevertheless, earlier studies have shown that
Lys-flanked polyleucine peptides are capable of inducing systematic acyl chain ordering and disordering (40, 41). We conclude
that little acyl chain stretch is observed in our system because the
Lys side chains in KALP23 are in a favorable environment in 14:0-PC.
The -NH3+ groups of KALP23, in the
extended snorkling conformation, are near the phosphates but slightly
outwards toward the aqueous phase (Table III). However, the lysine side
chains are flexible and, if not snorkling, they can stay even closer to
the position of the 14:0-PC phosphate region.
Biological Significance: Preferred Interface Positions of Trp and
Lys--
The selected combinations of peptides and lipids yield
information about the positions of Trp and Lys side chains in
transmembrane peptides. We propose that the tryptophan side
chain has a specific affinity for a well defined site near the
interface, with the indole imino moiety positioned near the center of
the lipid carbonyl region, and the fused aromatic rings in contact with
the lipid acyl chains. This location is in good agreement with the
membrane depth of NH-containing carbazole indole analogs, as determined by parallax analysis of fluorescence quenching (32, 42) but is on
average somewhat deeper in the membrane than NMR studies on other small
Trp analogs predict (43). In both studies, however, these water-soluble
analogs are not part of a transmembraneous peptide. It cannot be
concluded whether the lysine
-NH3+ group has a specific affinity
for the phosphate group. It is also possible that the side chain just
prefers a sufficiently polar environment, which is offered by a broad
interfacial region. Such an arrangement has been proposed for
amphipathic model peptides (33, 34). We propose a model in which the
Trp indole NH prefers a well defined position at the polar/apolar
interface near the lipid carbonyl region, while the lysine
-NH3+ group is located in a more
polar region, around the lipid phosphate group or slightly closer to
the aqueous phase. Such a position would be stabilized by electrostatic
-NH3+/phosphate interactions.
Analyses of protein x-ray structures have demonstrated that
lipid-exposed transmembrane helices are enriched in aromatic and charged residues near the helix termini and that statistically the
charged residues are positioned several Å closer to the termini than
the aromatic residues (44). This is in agreement with our conclusions.
Two x-ray structures of membrane proteins (cytochrome c
oxidase (45, 46) and cytochrome bc1 complex (47,
48)) contain phospholipids, although these are embedded within the complex and are not adjacent to it. One of the two
phosphatidylethanolamine lipids of the cytochrome
bc1 complex is in proximity to two tryptophans and two arginines, as depicted in Fig. 7.
The Trp indole moieties are in close contact with the lipid, with the
indole NH groups adjacent to the lipid carbonyl moiety. The Arg side
chains are positioned at a somewhat larger distance from the lipid and
are oriented perpendicular to the acyl chains, with the terminal charge of Arg40 slightly above the phosphate group. These
observations in a complex membrane protein are in full agreement with
our conclusions from model studies on simple peptides.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 7.
Corey-Pauling-Koltun model of a
phosphatidylethanolamine molecule embedded in the cytochrome
bc1 complex (1BCC in the Protein Data
Bank, Brookhaven National Laboratory, Upton, NY) from chicken heart
inner mitochondrial membrane (48), with stick models of
TrpC31, TrpC327, ArgG39,
and ArgG40, which are in proximity to the lipid. The
oxygen atoms (and phosphorus) of the lipid are shown in
dark, as are the NH groups of the Trp and Arg side chains.
Note that the tryptophans are located close to the glycerol oxygens,
whereas the arginines are pointing toward the more polar regions of the
lipid, above the phosphate group. The picture was generated using
InsightII (Molecular Simulations).
|
|
Since this study provides for the first time information on the
preferred positions of Trp and Lys relative to each other and relative
to the interface, it might prove useful to incorporate our data
explicitly in prediction methods for transmembrane segments of the many
proteins for which the structure has not yet been solved.
 |
ACKNOWLEDGEMENTS |
We thank Gerda de Korte for HPLC analysis and
Brigitta Angerstein for spin label synthesis.
 |
FOOTNOTES |
*
This work was supported by the Council for Chemical Sciences
with financial aid from the Netherlands Organization for Scientific Research, by National Institutes of Health Grant GM 34968 (to R. E. K. and D. V. G.), by NATO Grant CRG 950357, and by EMBO Fellowship ASTF 8778 (to M. R. R. de P.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed. Tel.: 31-30-2535512;
Fax: 31-30-2522478; E-mail: m.r.r.deplanque@chem.uu.nl.
2
ESR experiments were also performed with
18:1c-PC as host lipid. Again neither WALP23 nor KALP23, at
a 1:10 peptide/lipid molar ratio, induced a motionally restricted
component in spectra of the 14-SASL spin probe in these lipids at
30 °C.
3
M. R. R. de Planque, D. V. Greathouse,
R. E. Koeppe II, and J. A. Killian, unpublished observations.
 |
ABBREVIATIONS |
The abbreviations used are:
WALP, tryptophan-alanine-leucine peptide
Ac-GW2(LA)nW2A-ethanolamine;
ESR, electron spin resonance;
KALP, lysine-alanine-leucine peptide
Ac-GK2(LA)nK2A-amide;
PC, phosphatidylcholine;
18:1c-PC, 1,2-dioleoyl-sn-glycero-3-phosphocholine;
20:1c-PC, 1,2-dieicosenoyl-sn-glycero-3-phosphocholine;
22:1c-PC, 1,2-dierucoyl-sn-glycero-3-phosphocholine;
24:1c-PC, 1,2-dinervonoyl-sn-glycero-3-phosphocholine;
14:0-PC, 1,2-dimyristoyl-sn-glycero-3-phosphocholine;
n-SASL, n-(N-oxy-4,4-dimethyloxazolidin-2-yl) stearic
acid spin label;
L , liquid crystalline bilayer lipid
phase;
I, isotropic lipid phase, HII, inverse hexagonal
lipid phase;
HPLC, high pressure liquid chromatography.
 |
REFERENCES |
| 1.
|
Gil, T.,
Ipsen, J. H.,
Mouritsen, O. G.,
Sabra, M. C.,
Sperotto, M. M.,
and Zuckermann, M. J.
(1998)
Biochim. Biophys. Acta
1376,
245-266[Medline]
[Order article via Infotrieve]
|
| 2.
|
Marsh, D.,
and Horváth, L. I.
(1998)
Biochim. Biophys. Acta
1376,
267-296[Medline]
[Order article via Infotrieve]
|
| 3.
|
White, S. H.,
and Wimley, W. C.
(1998)
Biochim. Biophys. Acta
1376,
339-352[Medline]
[Order article via Infotrieve]
|
| 4.
|
Killian, J. A.
(1998)
Biochim. Biophys. Acta
1376,
401-416[Medline]
[Order article via Infotrieve]
|
| 5.
|
Landolt-Marticorena, C.,
Williams, K. A.,
Deber, C. M.,
and Reithmeier, R. A. F.
(1993)
J. Mol. Biol.
229,
602-608[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Von Heijne, G.
(1994)
Annu. Rev. Biophys. Biomol. Struct.
23,
167-192[Medline]
[Order article via Infotrieve]
|
| 7.
|
Reithmeier, R. A. F.
(1995)
Curr. Opin. Struct. Biol.
5,
491-500[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Ostermeier, C.,
Iwata, S.,
and Michel, H.
(1996)
Cur. Opin. Struct. Biol.
6,
460-466
|
| 9.
|
Doyle, D. A.,
Cabral, J. M.,
Pfuetzner, R. A.,
Kuo, A.,
Gulbis, J. M.,
Cohen, S. L.,
Chait, B. T.,
and MacKinnon, R.
(1998)
Science
280,
69-77[Abstract/Free Full Text]
|
| 10.
|
Killian, J. A.,
Salemink, I.,
De Planque, M. R. R.,
Lindblom, G.,
Koeppe, R. E., II,
and Greathouse, D. V.
(1996)
Biochemistry
35,
1037-1045[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Von Heijne, G.
(1986)
EMBO J.
5,
3021-3027[Medline]
[Order article via Infotrieve]
|
| 12.
|
De Planque, M. R. R.,
Greathouse, D. V.,
Koeppe, R. E., II,
Schäfer, H.,
Marsh, D.,
and Killian, J. A.
(1998)
Biochemistry
37,
9333-9345[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Greathouse, D. V.,
Koeppe, R. E., II,
Providence, L. L.,
Shobana, S.,
and Andersen, O. S.
(1999)
Methods Enzymol.
294,
525-550[Medline]
[Order article via Infotrieve]
|
| 14.
|
Goforth, R. L.,
Crawford, T.,
Van der Wel, P. C. A.,
Rhodes, N. E.,
Killian, J. A.,
and Greathouse, D. V.
(1999)
Biophys. J.
76,
A217
|
| 15.
|
Hubbell, W. L.,
and McConnell, H. M.
(1971)
J. Am. Chem. Soc.
93,
314-326[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Davis, J. H.,
Jeffrey, K. R.,
Bloom, M.,
Valic, M. I.,
and Higgs, T. P.
(1976)
Chem. Phys. Lett.
42,
390-394
[CrossRef] |
| 17.
|
Seelig, J.
(1978)
Biochim. Biophys. Acta
515,
105-140[Medline]
[Order article via Infotrieve]
|
| 18.
|
Cullis, P. R.,
and De Kruijff, B.
(1979)
Biochim. Biophys. Acta
559,
399-420[Medline]
[Order article via Infotrieve]
|
| 19.
|
Dieudonné, D.,
Gericke, G.,
Flach, C. R.,
Jiang, X.,
Farid, R. S.,
and Mendelsohn, R.
(1998)
J. Am. Chem. Soc.
120,
792-799[CrossRef]
|
| 20.
|
Ren, J.,
Lew, S.,
Wang, Z.,
and London, E.
(1997)
Biochemistry
36,
10213-10220[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Webb, R. J.,
East, J. M.,
Sharma, R. P.,
and Lee, A. G.
(1998)
Biochemistry
37,
673-679[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Morein, S.,
Strandberg, E.,
Killian, J. A.,
Persson, S.,
Arvidson, G.,
Koeppe, R. E., II,
and Lindblom, G.
(1997)
Biophys. J.
73,
3078-3088[Medline]
[Order article via Infotrieve]
|
| 23.
|
Lewis, B. A.,
and Engelman, D. M.
(1983)
J. Mol. Biol.
166,
211-217[Medline]
[Order article via Infotrieve]
|
| 24.
|
Greenfield, N.,
and Fasman, G. D.
(1969)
Biochemistry
8,
4108-4116[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
De Jongh, H. H. J.,
Goormagtigh, E.,
and Killian, J. A.
(1994)
Biochemistry
33,
14521-14528[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Chakrabartty, A.,
Kortemme, T.,
Padmanabhan, S.,
and Baldwin, R. L.
(1993)
Biochemistry
32,
5560-5565[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Marsh, D.
(1993)
New Compr. Biochem.
25,
41-66
|
| 28.
|
Marsh, D.
(1997)
Eur. Biophys. J.
26,
203-208[CrossRef]
|
| 29.
|
Marsh, D.
(1985)
in
Progress in Protein-Lipid Interactions
(Watts, A.
, and De Pont, J. J. H. H. M., eds), Vol. 1
, pp. 143-172, Elsevier, Amsterdam
|
| 30.
|
Hu, W.,
Lee, K. C.,
and Cross, T. A.
(1993)
Biochemistry
32,
7035-7047[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Koeppe, R. E., II,
Killian, J. A.,
and Greathouse, D. V.
(1994)
Biophys. J.
66,
14-24[Medline]
[Order article via Infotrieve]
|
| 32.
|
Kachel, K.,
Asuncion-Punzalan, E.,
and London, E.
(1995)
Biochemistry
34,
15475-15479[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Mishra, V. K.,
Palgunachari, M. N.,
Segrest, J. P.,
and Anantharamaiah, G. M.
(1994)
J. Biol. Chem.
269,
7185-7191[Abstract/Free Full Text]
|
| 34.
|
Mishra, V. K.,
and Palgunachari, M. N.
(1996)
Biochemistry
35,
11210-11220[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Wiener, M. C.,
and White, S. H.
(1992)
Biophys. J.
61,
434-447
|
| 36.
|
White, S. H.
(1994)
in
Membrane Protein Structure: Experimental Approaches
(White, S. H., ed)
, pp. 97-124, Oxford University Press, New York
|
| 37.
|
Wimley, W. C.,
and White, S. H.
(1996)
Nat. Struct. Biol.
3,
842-848[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Roux, M.,
Neumann, J. M.,
Hodges, R. S.,
Devaux, P. F.,
and Bloom, M.
(1989)
Biochemistry
28,
2313-2321[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Subczynski, W. K.,
Lewis, R. N. A. H.,
McElhaney, R. N.,
Hodges, R. S.,
Hyde, J. S.,
and Kusumi, A.
(1998)
Biochemistry
37,
3156-3164[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Huschilt, J. C.,
Hodges, R. S.,
and Davis, J. H.
(1985)
Biochemistry
24,
1377-1386[CrossRef]
|
| 41.
|
Nezil, F. A.,
and Bloom, M.
(1992)
Biophys. J.
61,
1176-1183[Medline]
[Order article via Infotrieve]
|
| 42.
|
Asuncion-Punzalan, E.,
Kachel, K.,
and London, E.
(1998)
Biochemistry
37,
4603-4611[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Yau, W.-M.,
Wimley, W. C.,
Gawrisch, K.,
and White, S. H.
(1998)
Biochemistry
37,
14713-14718[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Wallin, E.,
Tsukihara, T.,
Yoshikawa, S.,
Von Heijne, G.,
and Elofsson, A.
(1997)
Prot. Sci.
6,
808-815[Medline]
[Order article via Infotrieve]
|
| 45.
|
Tsukihara, T.,
Aoyama, H.,
Yamashita, E.,
Tomizaki, T.,
Yamaguchi, H.,
Shinzawa-Itoh, K.,
Nakashima, R.,
Yaono, R.,
and Yoshikawa, S.
(1996)
Science
272,
1136-1144[Abstract]
|
| 46.
|
Iwata, S.,
Ostermeier, C.,
Ludwig, B.,
and Michel, H.
(1995)
Nature
376,
660-669[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Iwata, S.,
Lee, J. W.,
Okada, K.,
Lee, J. K.,
Iwata, M.,
Rasmussen, B.,
Link, T. A.,
Ramaswamy, S.,
and Jap, B. K.
(1998)
Science
281,
64-71[Abstract/Free Full Text]
|
| 48.
|
Zhang, Z.,
Huang, L.,
Shulmeister, V. M.,
Chi, Y. I.,
Kim, K. K.,
Hung, L. W.,
Crofts, A. R.,
Berry, E. A.,
and Kim, S. H.
(1998)
Nature
392,
677-684[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Applied Biosystems.
(1993)
Applied Biosystems Model 433A Peptide Synthesizer User's Manual, Version 1.0
, Applied Biosystems, Foster City, CA
|
| 50.
|
Applied Biosystems.
(1993)
Applied Biosystems Research News
, pp. 1-12, Applied Biosystems, Foster City, CA
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Schmidtchen, M. Pasupuleti, M. Morgelin, M. Davoudi, J. Alenfall, A. Chalupka, and M. Malmsten
Boosting Antimicrobial Peptides by Hydrophobic Oligopeptide End Tags
J. Biol. Chem.,
June 26, 2009;
284(26):
17584 - 17594.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Lorin, B. Charloteaux, Y. Fridmann-Sirkis, A. Thomas, Y. Shai, and R. Brasseur
Mode of Membrane Interaction and Fusogenic Properties of a de Novo Transmembrane Model Peptide Depend on the Length of the Hydrophobic Core
J. Biol. Chem.,
June 22, 2007;
282(25):
18388 - 18396.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bowen and A. T. Brunger
Conformation of the synaptobrevin transmembrane domain
PNAS,
May 30, 2006;
103(22):
8378 - 8383.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Ulmschneider, D.P. Tieleman, and M. S.P. Sansom
The role of extra-membranous inter-helical loops in helix-helix interactions
Protein Eng. Des. Sel.,
December 1, 2005;
18(12):
563 - 570.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Sparr, W. L. Ash, P. V. Nazarov, D. T. S. Rijkers, M. A. Hemminga, D. P. Tieleman, and J. A. Killian
Self-association of Transmembrane {alpha}-Helices in Model Membranes: IMPORTANCE OF HELIX ORIENTATION AND ROLE OF HYDROPHOBIC MISMATCH
J. Biol. Chem.,
November 25, 2005;
280(47):
39324 - 39331.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Hernandez, D. Ferreira, C. Sinodis, K. Litton, and D. T. Brown
Single Amino Acid Insertions at the Junction of the Sindbis Virus E2 Transmembrane Domain and Endodomain Disrupt Virus Envelopment and Alter Infectivity
J. Virol.,
June 15, 2005;
79(12):
7682 - 7697.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Japelj, P. Pristovsek, A. Majerle, and R. Jerala
Structural Origin of Endotoxin Neutralization and Antimicrobial Activity of a Lactoferrin-based Peptide
J. Biol. Chem.,
April 29, 2005;
280(17):
16955 - 16961.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. W. Hofmann, K. Weise, J. Ollesch, P. Agrawal, H. Stalz, W. Stelzer, F. Hulsbergen, H. de Groot, K. Gerwert, J. Reed, et al.
De novo design of conformationally flexible transmembrane peptides driving membrane fusion
PNAS,
October 12, 2004;
101(41):
14776 - 14781.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Morisset, J.-M. Berjeaud, D. Marion, C. Lacombe, and J. Frere
Mutational Analysis of Mesentericin Y105, an Anti-Listeria Bacteriocin, for Determination of Impact on Bactericidal Activity, In Vitro Secondary Structure, and Membrane Interaction
Appl. Envir. Microbiol.,
August 1, 2004;
70(8):
4672 - 4680.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Eyre, L. Partridge, and J. M. Thornton
Computational analysis of {alpha}-helical membrane protein structure: implications for the prediction of 3D structural models
Protein Eng. Des. Sel.,
August 1, 2004;
17(8):
613 - 624.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Adam, L. Lins, V. Stroobant, A. Thomas, and R. Brasseur
Distribution of Hydrophobic Residues Is Crucial for the Fusogenic Properties of the Ebola Virus GP2 Fusion Peptide
J. Virol.,
February 15, 2004;
78(4):
2131 - 2136.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. G. Hernandez-Guzman, T. Higashiyama, W. Pangborn, Y. Osawa, and D. Ghosh
Structure of Human Estrone Sulfatase Suggests Functional Roles of Membrane Association
J. Biol. Chem.,
June 13, 2003;
278(25):
22989 - 22997.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Le Rumeur, Y. Fichou, S. Pottier, F. Gaboriau, C. Rondeau-Mouro, M. Vincent, J. Gallay, and A. Bondon
Interaction of Dystrophin Rod Domain with Membrane Phospholipids. EVIDENCE OF A CLOSE PROXIMITY BETWEEN TRYPTOPHAN RESIDUES AND LIPIDS
J. Biol. Chem.,
February 14, 2003;
278(8):
5993 - 6001.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Capener, H. J. Kim, Y. Arinaminpathy, and M. S.P. Sansom
Ion channels: structural bioinformatics and modelling
Hum. Mol. Genet.,
October 1, 2002;
11(20):
2425 - 2433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Hasler, G. Crambert, J.-D. Horisberger, and K. Geering
Structural and Functional Features of the Transmembrane Domain of the Na,K-ATPase beta Subunit Revealed by Tryptophan Scanning
J. Biol. Chem.,
May 4, 2001;
276(19):
16356 - 16364.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. A. Demmers, E. van Duijn, J. Haverkamp, D. V. Greathouse, R. E. Koeppe II, A. J. R. Heck, and J. A. Killian
Interfacial Positioning and Stability of Transmembrane Peptides in Lipid Bilayers Studied by Combining Hydrogen/Deuterium Exchange and Mass Spectrometry
J. Biol. Chem.,
September 7, 2001;
276(37):
34501 - 34508.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Langosch, B. Brosig, and R. Pipkorn
Peptide Mimics of the Vesicular Stomatitis Virus G-protein Transmembrane Segment Drive Membrane Fusion in Vitro
J. Biol. Chem.,
August 17, 2001;
276(34):
32016 - 32021.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-i. Ito, C. J. Oleschuk, C. Westlake, M. Z. Vasa, R. G. Deeley, and S. P. C. Cole
Mutation of Trp1254 in the Multispecific Organic Anion Transporter, Multidrug Resistance Protein 2 (MRP2) (ABCC2), Alters Substrate Specificity and Results in Loss of Methotrexate Transport Activity
J. Biol. Chem.,
October 5, 2001;
276(41):
38108 - 38114.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. A. Demmers, J. Haverkamp, A. J. R. Heck, R. E. Koeppe II, and J. A. Killian
Electrospray ionization mass spectrometry as a tool to analyze hydrogen/deuterium exchange kinetics of transmembrane peptides in lipid bilayers
PNAS,
March 28, 2000;
97(7):
3189 - 3194.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|